GenomeDx Biosciences
company
About
GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $25.38M
- Industries
- Biotechnology,Genetics,Health Care,Medical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 51 - 100
- Operating Status
- Active
GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$25.38M
GenomeDx Biosciences has raised a total of
$25.38M
in funding over 2 rounds. Their latest funding was raised on
Mar 9, 2016 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 9, 2016 | Series C | $25.38M | 1 |
Merck
|
— | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
